CPI-444 has also been shown to intensify the antitumor effect of adoptive metastases of HER2-specific CD8+T cells in tumor-bearing mice treated with cyclophosphamide and a novel gene-expressed whole-cell vaccine (GVAX) (10). The gene discussed is CD8A; the disease is neoplasm.